Determination of Metabolites in the Cerebellum of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposed Mice by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry

Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin elicits many harmful effects in tissues. Metabolomic changes and the associated pathway alterations caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the cerebellum, an area thought to be less affected by environmental alterations, remain unknown. Here, metabolomics was performed to identify endogenous metabolites that were associated with 2,3,7,8-tetrachlorodibenzo-p-dioxin in the cerebellum of 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated mice using Fourier transform ion cyclotron resonance mass spectrometry. Distinct peaks were located in two mass ranges, 210 m/z–420 m/z and 450 m/z–570 m/z. In principal component space, the high-dose group was clearly separated from the control group. Six metabolites associated with 2,3,7,8-tetrachlorodibenzo-p-dioxin dose were identified. The metabolite 1-palmitoyl lysophosphatidic acid increased with increasing doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin, indicating activation of the rat sarcoma pathway. Biosynthesis of the unsaturated fatty acid 18-hydroxyoleate was inhibited upon 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. The decrease in N-arachidonoyl taurine, implies that taurine increased, suggesting inhibition of neuronal signal transmission. A decrease in N-acetyl-aspartyl-glutamate has been associated with injury of the cerebellum through activation of N-methyl-D-aspartic acid receptors. An increase in glycerophosphoinositol suggests damage to blood–brain barrier function, and changes in purine metabolism were observed because inosine increased following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. These results suggest that 2,3,7,8-tetrachlorodibenzo-p-dioxin activates the rat sarcoma pathway, alters fatty acid biosynthesis and purine metabolism, inhibits neurotransmitter systems, and is harmful to blood–brain barrier function in the cerebellum.